Advertisement

Topics

$COCP Update on Clinical Development Program Evaluating CC-31244 for Ultra-Short Treatment of Hepatitis C Virus https://finance.yahoo.com/news/cocrystal-pharma-provides-clinical-development-130000390.html …

08:03 EST 22 Jan 2019 | Odi Bruckman

Update on Clinical Development Program Evaluating CC-31244 for Ultra-Short Treatment of Hepatitis C Virus https://finance.yahoo.com/news/cocrystal-pharma-provides-clinical-development-130000390.html …

Original Article: $COCP Update on Clinical Development Program Evaluating CC-31244 for Ultra-Short Treatment of Hepatitis C Virus https://finance.yahoo.com/news/cocrystal-pharma-provides-clinical-development-130000390.html …

NEXT ARTICLE

More From BioPortfolio on "$COCP Update on Clinical Development Program Evaluating CC-31244 for Ultra-Short Treatment of Hepatitis C Virus https://finance.yahoo.com/news/cocrystal-pharma-provides-clinical-development-130000390.html …"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Gastroenterology
Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...